AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast

Rhea-AI Summary

AIM ImmunoTech Inc. will hold a conference call and webcast on May 16, 2024, to discuss Q1 2024 operational and financial results. The call will be led by CEO Thomas K. Equels and Scientific Officer Christopher McAleer. Participants can join via phone or webcast on the aimimmuno.com website.

OCALA, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will host a conference call and webcast to discuss the Company’s Q1 2024 operational and financial results on Thursday, May 16, 2024, at 8:30 AM ET.

The call will be hosted by members of AIM’s leadership team, Thomas K. Equels, Chief Executive Officer and Christopher McAleer, PhD, Scientific Officer. Interested participants and investors may access the conference call by dialing (877) 407-9219 (domestic) or (201) 689-8852 (international) and referencing the AIM ImmunoTech Conference Call. The webcast will be accessible on the Events page of the Investors section of the Company’s website, aimimmuno.com, and will be archived for 90 days following the live event.

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s lead product is a first-in-class investigational drug called Ampligen^® (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system.

For more information, please visit aimimmuno.com and connect with the Company on X, LinkedIn, and Facebook.

FAQ

When will AIM ImmunoTech discuss their Q1 2024 financial results?

AIM ImmunoTech will discuss their Q1 2024 financial results on May 16, 2024.

Who will lead the conference call and webcast?

CEO Thomas K. Equels and Scientific Officer Christopher McAleer will lead the conference call and webcast.

How can participants access the conference call?

Participants can join the conference call by dialing (877) 407-9219 (domestic) or (201) 689-8852 (international) and referencing the AIM ImmunoTech Conference Call.

Where can the webcast be accessed?

The webcast will be available on the Events page of the Investors section of aimimmuno.com and will be archived for 90 days after the live event.